ASH23: Perseus Trial: DARA + VRd vs. Vrd Alone in ASCT-Eligible Patients | Pieter Sonneveld, MD, PhD

  Рет қаралды 930

International Myeloma Foundation

International Myeloma Foundation

Күн бұрын

Пікірлер: 1
@FOTOMOTOGP
@FOTOMOTOGP 10 ай бұрын
Daratumumab has been amazing for me. My Paraprotein level was 79%. I started a course of Daratumumab, Bortizemide, Thalidomide and Dexamethasone. Within weeks I suffered with severe peripheral neuropathy. My Bortizemide and Thalidomide were stopped. Daratumumab (with Dexamethasone) took my Paraprotein level to 0%. Thank you Daratumumab.
Answering Your Top Myeloma Questions: Maintenance Therapy, Imaging, Neuropathy, and More
12:24
ЛУЧШИЙ ФОКУС + секрет! #shorts
00:12
Роман Magic
Рет қаралды 27 МЛН
Walking on LEGO Be Like... #shorts #mingweirocks
00:41
mingweirocks
Рет қаралды 6 МЛН
Aspirin and cancer: the emerging evidence
54:01
Cardiff University School of Medicine
Рет қаралды 1,4 МЛН
Should we delay transplantation in patients with standard-risk multiple myeloma?
3:12
VJHemOnc – Video Journal of Hematology & HemOnc
Рет қаралды 2 М.
How diet triggers inflammation | Prof Philip Calder
14:09
How to recover from depression
1:02:36
Psychlopaedia.org
Рет қаралды 5 МЛН